Dicerna Pharmaceuticals Logo

Email this page: News Release

Dicerna Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

For security reasons, registration is required before you can use this feature.
* Indicates required field